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Abstract 
Cardiovascular and immune system pathophysiological changes and diseases  may be attributed to stress. 
Sometimes stress may be beneficial when it is not 'overwhelming' as it ,may improve performance in certain 
cases. Modern medicine is focusing on the close relationship between stress and cardiovascular and immune 
system morbidity  and mortality. New therapeutic strategies have to be set in place.Brief naturalistic stressors 
(such as exams) were associated with potentially adaptive upregulation of some parameters of natural immunity 
and downregulation of some functions of specific immunity; tended to suppress cellular immunity while 
preserved humoral immunity On the other hand chronic stressors were associated with suppression of both 
cellular and humoral immunity. In some cases, physical vulnerability as a function of age or disease also 
increased vulnerability to immune change during stressors.In mammals, physiological responses such as “fight 
or flight.” to chronic stressors , include changes that increase the delivery of oxygen and glucose to the heart and 
the large skeletal muscles. The changes in Immune responses to stressful situations may be part of these 
adaptive responses..Pychological challenges are capable of modifying various features of the immune response.  
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1. Introduction  
1.1. Stress 
Relationship between stress and pathophysiological disease is still scientifically questioned and only in the past 
decades, the stress concept and its association with health restrictions and diseases has become a major focus in 
medicine [1]. 
The modern stress concept is based on the fundamental work of Hans Selye who has studied the effects of stress 
on health and the physiological integrity of biological organisms [1–3]. Thereby, stress is now used as an 
umbrella term that summarizes the effects of psychosocial and environmental factors on physical or mental 
well-being [1,4,5]. 
Stressors elicit a stress response, which eventually leads to physiological, behavioral, and psychological 
adjustments in order to enhance the organism’s chances to ultimately survive [3,5–7]. The body uses and looses 
metabolic energy in order to repeatedly adapt to physical challenges and psychosocial threats. Keeping a 
dynamic physiological balance throughout ongoing (environmental) perturbations is a crucial step to maintain 
survival, biological integrity, and health [1,7]. 
The disturbing  stimulus can be defined as a state of disharmony, or threatened homeostasis/balance. 
Biochemical (neurotransmitter, peptides, steroids), physiological (heart rate, blood pressure), and behavioral 
(anxiety, depression, tension) concomitants of this response may co-mediate it [8]. Over time, we have referred 
to this normally protective response as stress, and the process of documenting the disturbance as the stress 
response [9]. 
Two major components of the autoregulatory stress response in vertebrates are known thus far, and they are 
both connected with the nervous system and its associated glands: the hypothalamic-pituitary-adrenal (HPA) 
axis and the sympathoadrenal medullary (SAM) system [10–13]. These two systems – HPA and SAM – are 
normally operating to maintain homeostasis. 
Stress response is susceptible to pathophysiological factors or processes and further has an impact upon many 
biological functions [1,4,10,11].The mediators of stress response can have both protective and harmful effects in 
organs like the heart, the brain and the immune system [7]. 
2. Structure  
2.1. Stress related cardiovascular diseases 
Despite clinical ‘intuition’, an ‘easy and clear’ relationship between stress and cardiovascular diseases had not 
been delineated, and this may have been due to the complexity of the stress phenomenon [3,4,6,7]. 
People who often get ‘stressed out’ and irritated or are always ‘on the run’ are classified as As type A pattern, 
tend to have a higher susceptibility to diseases of the circulatory system [14], hostility and anger have become a 
major focus in the context of ‘stressful’ factors with a greater cardiovascular risk [15]. (Figure 1). 
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Figure 1: Type A behavioral pattern.  
This pattern describes a characteristic behavioral coping strategy in challenging ('stressful') situations. It has 
been suspected to be related to a higher susceptibility to diseases of the circulatory system [14,16]. In a number 
of recent studies, however, researchers report no specific effect of Type A behavior on risk of coronary heart 
disease or other cardiovascular diseases [83]. Instead, latest evaluations of the epidemiological literature indicate 
definite connections between hostility and risk for cardiovascular disease [15,17,18]. This heightened risk is 
associated with an increased sympathetic activity [16,18], enhanced catecholamine/cortisol responses (stress 
responses) to behavioral stress, and elevated total serum cholesterol levels [16,18]. Research on the effects of 
behavioral phenomena on myocardial ischemia in coronary artery disease patients has provided a 
pathophysiological model for understanding the mechanisms by which mental stress can trigger clinical 
cardiovascular events [20]. Here, the activation of stress response-related pathways seems to be crucial and is 
capable of facilitating deleterious processes in the long-term: Via its actions on the central and autonomic 
nervous systems, stress can produce a cascade of regulatory responses that may actually lead, in vulnerable 
individuals, to myocardial ischemia, ventricular fibrillation, plaque rupture, or coronary thrombosis [19] 
Further, social support can buffer against the effects of stress while a disrupted, unstable social environment 
increases the stress related risk for cardiovascular incidents [20] 
In a study examining cynomolgus monkeys that had been put under social pressure (introduction of a stranger to 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2018) Volume 42, No  4, pp 16-26 
19 
 
a stable four-member social group), the social manipulation produced persistent sympathetic arousal and 
decreased the endothelial integrity of various vascular segments, leading to endothelial dysfunction – a 
precursor of atherosclerosis [20]. 
Interestingly, the detrimental effects of this experimentally applied psychosocial stress can be prevented by the 
use of beta-adrenergic (sympathetic) blocking agents [20]. 
2.2. Stress and Hypertension  
The etiology and pathophysiology of hypertension are complex. Besides primary, essential, or idiopathic forms, 
symptomatic (secondary) forms exist. Aging, atherosclerosis, risk factors, and sympathetic nervous system 
activity (stress) may play a critical role in secondary hypertension [21]. Stress has been shown to be important in 
vascular hypertension. It may either serve as a risk factor [22], induce blood pressure spikes, or increase an 
already elevated blood pressure [13,23,24]. Stress may even, in part, cause or contribute to the clinical onset of 
arterial hypertension in certain cases [22–24]. 
 
Figure 2: Stress stimulates the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system 
(SNS). Corticotropin releasing hormone (CRH), cortisol, and catecholamines like norepinephrine (NE) are 
released. In the vascular smooth muscle cell (VSMC), NE and adenosine triphosphate (ATP) interact, leading to 
vasoconstriction. Thus, the blood pressure (BP) increases, eventually facilitating arterial hypertension 
(references see text; [25] 
Animal models have illustrated the critical role of sympathetic arousal, associated with stress, in the 
development of hypertension [16]. In particular, acute stress is capable of immediately increasing the arterial 
blood pressure [23]. This is probably due to vasoconstriction, triggered by enhanced SNS activity [13] (Figure 
2). 
Additionally, chronic stress may lead to hypertension and prolonged/ /lasting side effects, eventually fixating 
vascular lesions and facilitating cardiovascular complications [20,21]. 
Taken together, stress contributes to the onset, development, and progression of a variety of cardiovascular 
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diseases. In particular, mental and psychosocial stressors apparently have a profound impact upon the 
circulatory system. Individual differences may further play a role, since susceptibility and reactivity in relation 
to stress show a subjective component. However, the SNS activity obviously represents a critical link, a crucial 
effector of the stress response and its potentially deteriorating influences on the cardiovascular system. 
2.3. Mechanisms of Stress Effects on the Immune System 
Virtually nothing is known about the psychological pathways linking stressors with the immune system. Many 
theorists have argued that affect is a final common pathway for stressors, (26), yet studies have enjoyed limited 
success in attempting to explain people’s immune responses to life experiences on the basis of their emotional 
states alone (27,28) 
A series of studies in the mid-1990s was able to show via beta-adrenergic blockade that activation of the 
sympathetic nervous system was responsible for the immune system effects of acute stressors  
Apart from these findings, however, little is known about biological mechanisms, especially with regard to more 
enduring stressors that occur in the real world. (29,30) 
Future studies could also benefit from a greater emphasis on behavior as a potential mechanism. This strategy 
has proven useful in studies of clinically depressed patients, in which decreased physical activity and 
psychomotor retardation (33), increased body mass (32), disturbed sleep (33), have been shown to explain some 
of the immune dysregulation evident in this population. There is already preliminary evidence, for instance, that 
sleep loss might be responsible for some of the immune system changes that accompany stressors ( 34) 
Stress, the Immune System, and Disease The most pressing question that future research needs to address is the 
extent to which stressor induced changes in the immune system have meaningful implications for disease 
susceptibility in otherwise healthy humans. 
In the 30 years since work in the field of psychoneuroimmunology began, studies have convincingly established 
that stressful experiences alter features of the immune response as well as confer vulnerability to adverse 
medical outcomes that are either mediated by or resisted by the immune system. However, with the exception of 
recent work on upper respiratory infection (35), studies have not yet tied these disparate strands of work 
together nor determined whether immune system changes are the mechanism through which stressors increase 
susceptibility todisease onset. In contrast, studies of vulnerable populations such as people with HIV have 
shown changes in immunity to predict disease progression (36). 
Cytokine expression represents a relatively new and promising example of an avenue for research linking stress, 
immune change, and disease. For example, chronic stress may elicit prolonged secretion of cortisol, to which 
white blood cells mount a counterregulatory response by downregulating their cortisol receptors. This 
downregulation, in turn, reduces the cells’ capacity to respond to anti-inflammatory signals and allows cytokine-
mediated inflammatory processes to flourish (37). 
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Stress therefore might contribute to the course of diseases involving excessive nonspecific inflammation (e.g., 
multiple sclerosis, rheumatoid arthritis, coronary heart disease) and thereby increase risk for excess morbidity 
and mortality (38). Another example of the importance of cytokines to clinical pathology is in asthma and 
allergy, in which emerging evidence implicates excess Th2 cytokine secretion in the exacerbation of these 
diseases (39). 
3. Discussion 
Stress implies a challenge (stimulus) that requires behavioral, psychological, and physiological changes 
(adaptations) to be successfully met, therefore using a state of hyperarousal for the initiation of necessary 
counteracting reactions [69]. The state of hyperarousal involves physiological mechanisms that are known as the 
stress/emergency response or fight-or-flight response, a set of physiological changes that occur in stressful 
situations and that prepare the ‘stressed’ organism either to fight – or flight. This evolutionarily old state of 
alertness had first been described by Walter Cannon in the first half of the 20th century [10,11]. 
Thereby, the profound physiological alterations observable in stress – involving the HPA axis and the SNS – 
exert effects upon the whole organism. Even though set in place to be helpful, stress may yet lead to onset, 
development, or progression of pathophysiological disease processes [1,4,7].  
This may be particularly true in chronic stress (or when an overwhelming acute stressor occurs), where the 
organism’s resources to withstand the ‘challenge of stress’ may prove to be insufficient in the long-term or may 
expire prematurely [1,3–5]. Hence, the stress response itself has the capacity to do harm [7].  
Further, when stress response mechanisms are not sufficient to meet the primary goal (adjustment to challenge 
or counteract the stressors, survival), the original stimulus/stressor may take over in a sense – the organism may 
‘capitulate’ [5]. It now may suffer deteriorating biological alterations, sickness, severe disease, or even death 
[5,7]. This state has been referred to as conservation-withdrawal or the giving up/given up state [1]. 
In particular, mental, behavioral, and psychosocial stressors are of importance. These findings correspond to 
similar outcomes obtained in immunological diseases [7]. 
However, with regard to cardiovascular diseases, stress most often happens to be deleterious: Since sympathetic 
nervous system activity is increased in stress [39] and the circulatory system obviously/by nature is sensitive to 
alterations in autonomic activity levels [21,40–42], stress – chronic stress in particular – is capable of 
thoroughly elevating the overall and specific cardiovascular risk [21,39]. 
In this way, some of the negative effects that stress triggers in the circulatory system resemble inflammatory 
processes: As stress affects the immune system, pathophysiological pathways activated here may also be 
stimulated and become important in certain cardiovascular diseases (e.g, myocardial infarction, 
atherosclerosis/endothelial dysfunction) [7,39]. 
This is especially key since the cellular immune response initiated by the macrophage is important for the 
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initiation and progression of atherosclerosis [64]. In addition to SNS and HPA pathways (involving 
norepinephrine and cortisol) and the cellular immune response, NO signaling also seems to be relevant in stress-
related cardiovascular diseases [7,10,15, 16,43,44,46]. However, the concrete pathophysiological mechanisms, 
molecular autoregulatory signaling pathways, and interrelationships involved are not totally understood yet, and 
further research is necessary to get a more complete picture [50]. 
Stress levels apparently are high and still growing in the ‘western world’ [1,21,50]. This fact may explain the 
rising – subjective – perception of stress in industrialized countries (enhanced perception of acute and chronic 
stress) [1,4], and the elevated risk for the development of diseases of the circulatory system . ‘Life style’ has 
become a central focus of prevention [1]. This ‘epidemic of stress’ [1] that has occurred in the west in the last 
decades runs the risk of becoming a critical medical issue: New strategies need to be put in place to stop the 
detrimental results that stress can have in cardiovascular patients [4,21,39]. Thus, stress management, cognitive 
behavioral strategies, and the use of relaxation response techniques are of growing future importance [1,50]. 
Immunity, its cytokine profile, and its regulation by anti-inflammatory agents such as cortisol, may determine 
the disparate effects of different kinds of stressors. 
4. Conclusion 
Stress-related disease emerges, predominantly, out of the fact that we so often activate a physiological system 
that has evolved for responding to acute physical emergencies, but we turn it on for months on end, worrying 
about mortgages, relationships, and promotions.   
A strong evidence for an importance of stress in disease processes related to the circulatory system and immune 
system Stress plays a significant role in susceptibility, progress, and outcome of cardiovascular diseases. In 
particular, stress may cause or exacerbate disease processes depending on the type of stressor involved (e.g, 
physical, chemical, biological, mental, psychosocial etc.) and/or the duration of its influence on an organism. 
Stress contributes to the onset, development, and progression of a variety of cardiovascular diseases. Here, 
mental and psychosocial stressors have a profound impact, and in this regard, the sympathetic nervous system 
represents a generally important effector of the stress response with potentially deleterious influences on the 
cardiovascular system.  Subjective or individual differences have to be taken into account too. This fact can 
make it difficult to predict an expected result following the experience of challenging stimuli (stressors) that are 
able to evoke the stress response and lead to physiological, psychological, and behavioral adjustments.  
Worry is more likely to result in stress-related immune change than objective experience and the idea that stress-
related immune change results in stress related disease. Though the results of the meta-analysis were not 
encouraging on the first point, many of these studies suffered from methodological limitations.  
We hope that these results will inform investigations that go beyond the relationship between a stressful event 
and an immune parameter to investigate the psychological phenomena that mediate that relationship. Finally, 
these results can also inform investigations into stress, immunity, and disease process. Whether the disease is 
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characterized by natural or specific  
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